
pmid: 15269611
Magnetic resonance spectroscopy (MRS) is a validated noninvasive method for evaluation of possible malignant tumor and lymph nodes of the head and neck. From its roots as a budding research application, it has made the critical transition to a widespread clinical tool. MRS analyzes the tissue at a molecular level and searches for the presence of specific metabolites, which are markers for malignancy. Differentiation of benign from malignant neoplasm, detection of recurrence of malignant tumor and noninvasive treatment monitoring of treated or untreated tumor are some of the important utilities of MRS. One dimensional 1H-MRS is the most popular and promising technique for spectroscopic analysis while P-31 MRA and two-dimensional correlated spectroscopy (2D COSY) have also showed some promise. This article describes the application of magnetic resonance spectroscopy for evaluation of malignant tumors of the neck.
Diagnosis, Differential, Magnetic Resonance Spectroscopy, Head and Neck Neoplasms, Lymphatic Metastasis, Biomarkers, Tumor, Carcinoma, Squamous Cell, Humans, Neoplasm Recurrence, Local
Diagnosis, Differential, Magnetic Resonance Spectroscopy, Head and Neck Neoplasms, Lymphatic Metastasis, Biomarkers, Tumor, Carcinoma, Squamous Cell, Humans, Neoplasm Recurrence, Local
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 26 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
